Gene · 1595
Papers2,112
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,112
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pulmonary Aspergillosis in Immunocompromised Critically Ill Patients: Prevalence, Risk Factors, Clinical Features and Diagnosis-A Narrative Review. | J Fungi (Basel) | 2025 | 41003163 | PubTator, text mining | PubMed |
| Multi-modal characterization of metabolic and immune gene clusters in adrenocortical carcinoma treatment. | NPJ Precis Oncol | 2025 | 40968257 | PubTator, text mining | PubMed |
| Revealing the catalytic mechanism of the Fe(II)/2-oxoglutarate-dependent human epigenetic modifying enzyme ALKBH5. | Cell Rep Phys Sci | 2025 | 40963693 | PubTator, text mining | PubMed |
| Expansion of genotype/phenotype correlation in an individual with compound heterozygous variants in CYP51A1 and congenital cataract. | Mol Genet Metab | 2025 | 40912167 | PubTator, text mining | PubMed |
| Leveraging genome and transcriptome sequencing to decipher fungicide resistance mechanisms in crop pathogenic fungi: current status and prospects. | Pest Manag Sci | 2025 | 40891462 | PubTator, text mining | PubMed |
| Epidemiology, risk factors, and antifungal susceptibility analysis of Candida tropicalis and non-C.tropicalis candidemia. | BMC Infect Dis | 2025 | 40890646 | PubTator, text mining | PubMed |
| Schinzel-Giedion syndrome: communication, feeding and motor skills in 16 individuals. | Neurogenetics | 2025 | 40859069 | PubTator, text mining | PubMed |
| Eumycetoma: pathogenesis, current treatments, and the search for new drugs. | Appl Microbiol Biotechnol | 2025 | 40830304 | PubTator, text mining | PubMed |
| Comparative Evaluation of Toxicity End Points in Unicellular Bioassays for Environmental Pollutant Assessment. | Environ Sci Technol | 2025 | 40829778 | PubTator, text mining | PubMed |
| Novel Amino Derivatives and Carboxamides of Chromen-2-one: Synthesis, Antimicrobial Activity, and Molecular Docking Studies. | Chem Asian J | 2025 | 40742272 | PubTator, text mining | PubMed |
| Ferroptosis: a novel pharmacological mechanism against multiple myeloma. | Front Pharmacol | 2025 | 40735482 | PubTator, text mining | PubMed |
Maternal application of tropical antifungal medication is associated with reduced steroid hormone levels during minipuberty and shorter anogenital distance in offspring from 3 months to 9 years of age: Odense Child Cohort. | Reprod Toxicol | 2025 | 40706775 | PubTator, text mining | PubMed |
| Genomic insights into the dermatophyte Trichophyton indotineae in Singapore: Resistance and transmission dynamics. | Med Mycol | 2025 | 40690276 | PubTator, text mining | PubMed |
| Releases of inhibition mechanisms and binding of antifungal compounds against validated proteins for drug design post-WHO priority list: A review. | Int J Biol Macromol | 2025 | 40685049 | PubTator, text mining | PubMed |
| CYP51A1 in health and disease: from sterol metabolism to regulated cell death. | Cell Death Discov | 2025 | 40659633 | PubTator, text mining | PubMed |
| Design, Synthesis, and In Vitro Evaluation of the Leishmanicidal Activity of New Aromatic Symmetrical 1,4-Disubstituted 1,2,3-Bistriazoles. | ACS Omega | 2025 | 40657064 | PubTator, text mining | PubMed |
| Exploring Novel Y140F/H Mutant Fungal CYP51 Inhibitors: A Molecular Docking and Dynamics Study on Thiophene Compounds. | J Pharm Bioallied Sci | 2025 | 40655603 | PubTator, text mining | PubMed |
| Designing drugs against leishmaniasis: is targeting the sterol biosynthesis pathway the answer? | Expert Opin Drug Discov | 2025 | 40650542 | PubTator, text mining | PubMed |
| Gastric mucosal differentially expressed genes after bariatric surgery: Effects on sterol-related pathways. | J Steroid Biochem Mol Biol | 2025 | 40609801 | PubTator, text mining | PubMed |
| BHLHA15 promotes cervical cancer cholesterol synthesis and tumor progression. | Cell Signal | 2025 | 40581267 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1595/papers?page=4